Patent Assignment
Reel/Frame 050169/0778
Change of Address of Assignee
Recorded: 2019-04-15
Pages: 18
Assignor
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Executed: 2018-07-01
Assignee
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
4-7 HANABATA-CHO, CHUOU-KU, KUMAMOTO-SHI, KUMAMOTO, 860-0806, JAPAN
Covered Properties
(43)
Medicinal Compositions for Treating and Preventing Diseases Based on Abnormal Blood Coagulation
Pharmaceutically Stable Hemostatic Compositions
Method for Enhancing Efficacy of Preparation of Monoclonal Antibody
Process for Producing Albumin Preparation
Process for Preparing Variant of Erysipelothrix Rhusiopathiae Surface Protective Antigen in E. Coli
Method for Improving Antibody
Modified Transposon Vector and Its Use
Method for Quantification of Neurotoxin
Process for Preparing Live Smallpox Vaccine
Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen
Solid Fibrinogen Preparation
Method for Enhancing Immune Response with Peptide
Novel Adamts-13 Mutant
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Human Anti-Amyloid Beta Peptide Antibody and Fragment of Said Antibody
Method and Kit for Detecting Antibody to Avibacterium Paragallinarum
Process for Preparing Variant of Erysipelothrix Rhusiopathiae Surface Protective Antigen in E. Coli
Process for Preparing Bioabsorbable Sheet Preparation Holding Thrombin
Method for Using Inactivated Japanese Encephalitis Virus Particles as Adjuvant
Modified Amyloid Beta Peptide
Process for Preparing Inclusion Body-Forming Protein
Recombinant Avian Infectious Coryza Vaccine and Process for Preparing Same
Method for Enhancing Immune Response with Peptide
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Modified Peptide Vaccine Derived from Influenza M2
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Type A2 Botulinum Toxin Preparation
Adjuvant Composition Containing Citrulline
Method for Enhancing Immune Response with Peptide
Novel Adamts-13 Mutant
Lps Vaccine
Novel Adamts-13 Mutant
Artificial Blood Vessel Using Decellularized Blood Vessel Sheet
Hybrid Gel Comprising Particulate Decellularized Tissue
Application:
14/888,871 →
Publication:
US 2016/0051731
Anti-Transthyretin Human Antibody
Anti-Transthyretin Humanized Antibody
Adjuvant Composition Containing Citrulline
Method for Monomerizing Matrix Metalloproteinase 7 (Mmp-7) Aggregate
Anti-Adhesion Material and Substitute Biomembrane Using Decellularized Tissue
Lps Vaccine
Multivalent Dengue Vaccine Composition Comprising a Mixture of Attenuated Dengue Viruses from Different Serotypes
Method for Improving Antibody
Diagnostic Agent and Medicine Comprising ADAMTS13 as Main Ingredient
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 15, 2004
From: AKAKI, TATSUYA; TOMOKIYO, KAZUHIKO; NAKATOMI, YASUSHI; TESHIMA, KAORI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 015219/0400 →
Assignment of Assignor's Interest
Sep 13, 2006
From: TAGAWA, RIKIICHI; HAYASE, YOSHIHIRO; MAEMURA, KOTA; TANIGAWA, HISASHI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 018238/0476 →
Assignment of Assignor's Interest
Sep 13, 2006
From: MURAKAMI, TOSHIO; HIGUCHI, HIROFUMI; MAKIZUMI, KEIICHI; MAEDA, TOSHIHIRO
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 018238/0302 →
Assignment of Assignor's Interest
Aug 30, 2007
From: TORIKAI, MASAHARU; NAKASHIMA, TOSHIHIRO
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 019772/0081 →
Assignment of Assignor's Interest
Jan 17, 2008
From: KAMINAKA, KAZUYOSHI; MAEDA, HIROAKI; HIRASHIMA, MASAKI; KAWAMURA, RYOICHI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 020377/0190 →
Assignment of Assignor's Interest
Jul 2, 2008
From: USHIJIMA, TOSHIHIRO; SAKAGUCHI, MASASHI; TOKUNAGA, EIJI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 021182/0982 →
Assignment of Assignor's Interest
Dec 16, 2008
From: HARAKAWA, TETSUHIRO; NAKANO, HIROTOSHI; TORII, YASUSHI; OKUDA, SACHIO
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE; JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES
Reel/Frame 021988/0067 →
Assignment of Assignor's Interest
Mar 5, 2009
From: KANEHARA, TOMOMI; YOKOTE, HIROYUKI; OHKUMA, KUNIO; KURANAGA, MASAHIKO
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE; JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES
Reel/Frame 022348/0423 →
Assignment of Assignor's Interest
Apr 27, 2009
From: HARAKAWA, TETSUHIRO; NAKANO, HIROTOSHI; TORII, YASUSHI; GOTO, YOSHITAKA
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 022604/0394 →
Assignment of Assignor's Interest
Oct 22, 2009
From: MATSUDA, JUNICHI; KAMINAKA, KAZUYOSHI; NOZAKI, CHIKATERU
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 023411/0175 →
Assignment of Assignor's Interest
Nov 11, 2009
From: MIYAGAWA, SHINICHI; ARAKI, TATSUYA; HAMURO, TSUTOMU; OKUDA, MIKA
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 023503/0309 →
Assignment of Assignor's Interest
Dec 30, 2009
From: SOEJIMA, KENJI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 023716/0033 →
Assignment of Assignor's Interest
Apr 16, 2010
From: SOEJIMA, KENJI; IMAMURA, TAKAYUKI; KAWAMURA, RYOICHI; NAKATAKE, HIROSHI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 024247/0190 →
Assignment of Assignor's Interest
Aug 12, 2010
From: USHIJIMA, TOSHIHIRO; IMAMURA, TAKASHI; SAKAMOTO, RYUICHI; SAKAGUCHI, MASASHI
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 024828/0768 →
Assignment of Assignor's Interest
Apr 26, 2011
From: NAKATAKE, HIROSHI; META, AKIHIRO; SUENAGA, KIYOTAKA; HIRASHIMA, MASAKI
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE; TEIJIN PHARMA LIMITED
Reel/Frame 026180/0201 →
Change of Name
Jan 16, 2013
From: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 029636/0944 →
Corporate Address Change
Jan 16, 2013
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 029637/0102 →
Corrective Assignment to Correct the Appln. No. Against Which Documents Were Previously Recorded on Reel 021988 Frame 0067. Assignor(S) Hereby Confirms the Appln. No Is 12/298,908 and Not 12/195,318.
Jul 9, 2013
From: HARAKAWA, TETSUHIRO; NAKANO, HIROTOSHI; TORII, YASUSHI; OKUDA, SACHIO
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH 'LNSTITL.YI'E; JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES
Reel/Frame 030792/0401 →
Assignment of Assignor's Interest
Aug 1, 2014
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE UNIVERSITY OF TOKUSHIMA
Reel/Frame 033445/0308 →
Change of English Name
Jan 28, 2016
From: THE UNIVERSITY OF TOKUSHIMA
To: TOKUSHIMA UNIVERSITY
Reel/Frame 037630/0710 →
Assignment of Assignor's Interest
Oct 27, 2016
From: TEIJIN PHARMA LIMITED
To: TEIJIN LIMITED
Reel/Frame 040148/0504 →
Assignment of Assignor's Interest
Jan 15, 2020
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: KM BIOLOGICS CO., LTD.
Reel/Frame 051520/0971 →
Assignment of Assignor's Interest
Aug 29, 2022
From: KM BIOLOGICS CO., LTD.
To: MEIJI ANIMAL HEALTH CO., LTD.
Reel/Frame 060927/0915 →
Assignment of Assignor's Interest
Oct 31, 2024
From: KM BIOLOGICS CO., LTD.
To: CUREDISC CORPORATION
Reel/Frame 069090/0119 →
Assignment of Assignor's Interest
Oct 31, 2024
From: TEIJIN LIMITED
To: CUREDISC CORPORATION
Reel/Frame 069090/0146 →